Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2015
At a glance
- Drugs Sirolimus (Primary)
- Indications Cutaneous T-cell lymphoma
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Jun 2015 Status changed from recruiting to withdrawn prior to enrolment as per ClinicalTrials.gov record.
- 10 Apr 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.